Prediction of Oral Absorption of Anionic Drugs that are Absorbed by the Monocarboxylic Acid Transport System
一元羧酸转运系统吸收的阴离子药物的口服吸收预测
基本信息
- 批准号:11672216
- 负责人:
- 金额:$ 1.28万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1999
- 资助国家:日本
- 起止时间:1999 至 2000
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Transcellular transport of carbenicillin (CBPC) and caridacillin (CIPC) through Caco-2 cell monolayer in the apical to basal direction was measured. CBPC is used pareterally because of poor absorption from the intestine, whereas CIPC is a prodrug of CBPC and is orally administered. Caco-2 cells were cultured on Transwell and the transport was measured at apical pH=6.0 and basal pH=7.4. Permeability of CIPC through Caco-2 cell monolayer was ca. 40-fold greater than that of CBPC, indicating that improved absorption of CIPC is due to much faster transport through the intestinal epithelial cells. Moreover, it was shown that CIPC, not CBPC, was transported by the monocarboxylic acid transport system that is located at the epithelial cells. It is probably true that modification of chemical structure from CBPC to CIPC resulted in much greater affinity to the transport system, which in turn resulted in greater absorption of the prodrug.Transport of cloxacillin (MCIPC), dicloxacillin (MDIPC), phenethicillin (PEPC), phenoxymethylpenicillin (PCV) and propicillin (PPPC) through Caco-2 cell monolayer was measured. Permeability of these drugs ranged from 0.8 to 1.0 x 10^<-6> cm/s. If we assume that these drugs are absorbed only by passive diffusion, extent of absorption after oral administration should be 10-20% of the dose (S.Chong et al., Pharm.Res.13 : 120-123, 1996). However, extent of oral absorption of these drugs in humans is 45-86%, which is much greater than that predicted assuming passive diffusion. The results suggest that a transport system, most probably the monocarboxylic acid transport system, is involved in the absorption of these drugs since these drugs have a carboxylic acid moiety and exist as mono-anion at physiological pH.Moreover, in our previous study, it was demonstrated that these drugs have affinity to the monocarboxylic acid transport system.
测量了羧卞西林 (CBPC) 和卡里西林 (CIPC) 通过 Caco-2 细胞单层从顶端到基底方向的跨细胞转运。 CBPC 由于肠道吸收差而以非胃肠道方式使用,而 CIPC 是 CBPC 的前药并口服给药。 Caco-2细胞在Transwell上培养,并在顶端pH=6.0和基础pH=7.4下测量转运。 CIPC 通过 Caco-2 细胞单层的渗透性约为。比 CBPC 高 40 倍,表明 CIPC 吸收的改善是由于通过肠上皮细胞的运输速度更快。此外,研究表明 CIPC,而不是 CBPC,是由位于上皮细胞的一元羧酸转运系统转运的。化学结构从 CBPC 修改为 CIPC 可能确实会导致与转运系统的亲和力更大,从而导致前药的吸收更大。氯唑西林 (MCIPC)、双氯西林 (MDIPC)、非奈西林 (PEPC) 的转运、苯氧基甲基青霉素 (PCV) 和丙匹西林 (PPPC) 通过 Caco-2 细胞单层进行测量。这些药物的渗透性范围为0.8至1.0×10 ^ -6 cm/s。如果我们假设这些药物仅通过被动扩散吸收,则口服给药后的吸收程度应为剂量的10-20%(S.Chong等人,Pharm.Res.13:120-123,1996)。然而,这些药物在人体中的口服吸收程度为 45-86%,这比假设被动扩散的预测要高得多。结果表明,转运系统(很可能是一元羧酸转运系统)参与了这些药物的吸收,因为这些药物具有羧酸部分并且在生理pH下以单阴离子形式存在。此外,在我们之前的研究中,它已证明这些药物对单羧酸转运系统具有亲和力。
项目成果
期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Li YH, Ito K, Tsuda Y, Kohda R, Yamada H, Itoh T.: "Mechanism of intestinal absorption of of an orally active β-lactam prodrug : Uptake and transport of caridacillin in Caco-2 cells."J.Pharmacol.Exp.Ther.. 290. 958-964 (1999)
Li YH、Ito K、Tsuda Y、Kohda R、Yamada H、Itoh T.:“口服活性 β-内酰胺前药的肠道吸收机制:Caco-2 细胞中卡里西林的摄取和转运。”实验.. 290. 958-964 (1999)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Li YH, Tanno M, Itoh T, Yamada H.: "Role of the monocarboxylic acid transport system in the intestinal absorption of an orally active β-lactam prodrug : Caridacillin as a model."Int.J.Pharmaceut. 191. 151-159 (1999)
Li YH、Tanno M、Itoh T、Yamada H.:“单羧酸转运系统在口服活性 β-内酰胺前药肠道吸收中的作用:Caridacillin 作为模型。”Int.J.Pharmaceut。191。151- 159 (1999)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Itoh T, Ono K, Koido K, Li YH, Yamada H.: "Stereoselectivity of the folate transporter in rabbit small intestine : Studies with amethopterin enantiomers."Chirality. 13. 164-169 (2001)
Itoh T、Ono K、Koido K、Li YH、Yamada H.:“兔小肠叶酸转运蛋白的立体选择性:氨甲蝶呤对映体的研究。”手性。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
T.Itoh,K.Ono,K.Koido,Y-H.Li,H.Yamada: "Stereoselectivity of the folate transporter"Chirality. (in press). (2001)
T.Itoh,K.Ono,K.Koido,Y-H.Li,H.Yamada:“叶酸转运蛋白的立体选择性”手性。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
T.Itoh,K.Ono,K.Koido,Y-H.Li,H.Yamada: "Stereoselectivity of the folate transporter"Chirality. 13. 164-169 (2001)
T.Itoh,K.Ono,K.Koido,Y-H.Li,H.Yamada:“叶酸转运蛋白的立体选择性”手性。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ITOH Tomoo其他文献
ITOH Tomoo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ITOH Tomoo', 18)}}的其他基金
Quantitative prediction of oral bioavailability independent of metabolic pathway
独立于代谢途径的口服生物利用度的定量预测
- 批准号:
17K08423 - 财政年份:2017
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Quantitative prediction of bioavailability and drug-drug interactions of orally administered drugs
口服药物生物利用度和药物相互作用的定量预测
- 批准号:
26460204 - 财政年份:2014
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Quantitative prediction of first pass metabolism and drug-drug interactions for orally administered drugs
口服药物首过代谢和药物相互作用的定量预测
- 批准号:
21590174 - 财政年份:2009
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Quantitative prediction of drug-drug interactions in the intestinal first pass metabolism
肠道首过代谢中药物相互作用的定量预测
- 批准号:
19590157 - 财政年份:2007
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
无人码头场景下集装箱运输车自动驾驶关键理论与技术
- 批准号:62333017
- 批准年份:2023
- 资助金额:228 万元
- 项目类别:重点项目
基于WSN和MI云平台的自行式模块运输车集群预测性智能运维系统的理论及关键技术
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
肺炎支原体外排泵ABC Transporter在大环内酯类耐药中的作用机制研究
- 批准号:81672062
- 批准年份:2016
- 资助金额:25.0 万元
- 项目类别:面上项目
巷道重载分体运输车转向协调电液控制系统理论研究
- 批准号:51175448
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
低氧诱导因子(HIF)以及氧化还原系统(redox)与肿瘤多药耐药(MDR)的相互作用
- 批准号:31070750
- 批准年份:2010
- 资助金额:34.0 万元
- 项目类别:面上项目
相似海外基金
2023 Multi-Drug Efflux Systems: Targeting the Mechanisms and Regulation of Multi-Drug Transporters for Advancing Health during a Pandemic GRC/GRS
2023 多药物外排系统:针对多药物转运蛋白的机制和调节,以在大流行 GRC/GRS 期间促进健康
- 批准号:
10614335 - 财政年份:2023
- 资助金额:
$ 1.28万 - 项目类别:
Oral mRNA Nanotherapy for Bleeding Disorder
口服 mRNA 纳米疗法治疗出血性疾病
- 批准号:
10750040 - 财政年份:2023
- 资助金额:
$ 1.28万 - 项目类别:
PBPK Modeling & Simulation to Predict Transporter-Mediated Drug Secretion into Human Breast Milk
PBPK 建模
- 批准号:
10706040 - 财政年份:2023
- 资助金额:
$ 1.28万 - 项目类别:
Discovery and development of novel glycine transporter-2 inhibitors for the treatment of neuropathic pain
发现和开发用于治疗神经性疼痛的新型甘氨酸转运蛋白 2 抑制剂
- 批准号:
10592522 - 财政年份:2022
- 资助金额:
$ 1.28万 - 项目类别:
Pharmacological Npt2a inhibition as a treatment for hyperphosphatemia in chronic kidney disease
药理学 Npt2a 抑制治疗慢性肾病高磷血症
- 批准号:
10293557 - 财政年份:2021
- 资助金额:
$ 1.28万 - 项目类别: